AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
SELECTION AND IMMUNOMAGNETIC PURGING OF PERIPHERAL-BLOOD CD34-CELL NON-HODGKINS-LYMPHOMAS( CELLS FOR AUTOLOGOUS TRANSPLANTATION IN B)
Authors: PICHERT G SCHMITTER D WIDMER L JOST LM KURRER MO MAURER R STAHEL RA
Citation: G. Pichert et al., SELECTION AND IMMUNOMAGNETIC PURGING OF PERIPHERAL-BLOOD CD34-CELL NON-HODGKINS-LYMPHOMAS( CELLS FOR AUTOLOGOUS TRANSPLANTATION IN B), Annals of oncology, 9(1), 1998, pp. 51-54
THE 5'-FLANKING REGION OF HUMAN CD24 GENE HAS CELL-TYPE-SPECIFIC PROMOTER ACTIVITY IN SMALL-CELL LUNG-CANCER
Authors: PASS MK QUINTINI G ZARN JA ZIMMERMANN SM SIGRIST JA STAHEL RA
Citation: Mk. Pass et al., THE 5'-FLANKING REGION OF HUMAN CD24 GENE HAS CELL-TYPE-SPECIFIC PROMOTER ACTIVITY IN SMALL-CELL LUNG-CANCER, International journal of cancer, 78(4), 1998, pp. 496-502
SYNERGISTIC CYTOTOXICITY OF BCL-2 ANTISENSE OLIGODEOXYNUCLEOTIDES ANDETOPOSIDE, DOXORUBICIN AND CISPLATIN ON SMALL-CELL LUNG-CANCER CELL-LINES
Authors: ZANGEMEISTERWITTKE U SCHENKER T LUEDKE GH STAHEL RA
Citation: U. Zangemeisterwittke et al., SYNERGISTIC CYTOTOXICITY OF BCL-2 ANTISENSE OLIGODEOXYNUCLEOTIDES ANDETOPOSIDE, DOXORUBICIN AND CISPLATIN ON SMALL-CELL LUNG-CANCER CELL-LINES, British Journal of Cancer, 78(8), 1998, pp. 1035-1042
MOLECULAR INTERVENTION IN SMALL-CELL LUNG-CANCER
Authors: STAHEL RA ZANGEMEISTERWITTKE U PASS MK
Citation: Ra. Stahel et al., MOLECULAR INTERVENTION IN SMALL-CELL LUNG-CANCER, European journal of cancer, 33, 1997, pp. 1288-1288
INDEX OF PRETREATMENT INTENSITY PREDICTS OUTCOME OF HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION IN CHEMOSENSITIVERELAPSE OF HODGKINS-DISEASE
Authors: JOST LM WIDMER L HONEGGER HP STAHEL RA
Citation: Lm. Jost et al., INDEX OF PRETREATMENT INTENSITY PREDICTS OUTCOME OF HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION IN CHEMOSENSITIVERELAPSE OF HODGKINS-DISEASE, Annals of oncology, 8(8), 1997, pp. 785-790
SINGLE-AGENT GEMCITABINE VERSUS CISPLATIN-ETOPOSIDE - EARLY RESULTS OF A RANDOMIZED PHASE-II STUDY IN LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG-CANCER
Authors: MANEGOLD C BERGMAN B CHEMAISSANI A DORNOFF W DRINGS P KELLOKUMPULEHTINEN P LIIPPO K MATTSON K VONPAWEL J RICCI S SEDERHOLM C STAHEL RA WAGENIUS G VONWALREE N TENBOKKELHUININK W
Citation: C. Manegold et al., SINGLE-AGENT GEMCITABINE VERSUS CISPLATIN-ETOPOSIDE - EARLY RESULTS OF A RANDOMIZED PHASE-II STUDY IN LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 8(6), 1997, pp. 525-529
RANDOMIZED TRIAL SHOWING EQUIVALENT EFFICACY OF FILGRASTIM 5 MU-G KG/D AND 10 MU-G/KG/D FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HIGH-RISK LYMPHOMAS/
Authors: STAHEL RA JOST LM HONEGGER H BETTS E GOEBEL MEM NAGLER A
Citation: Ra. Stahel et al., RANDOMIZED TRIAL SHOWING EQUIVALENT EFFICACY OF FILGRASTIM 5 MU-G KG/D AND 10 MU-G/KG/D FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HIGH-RISK LYMPHOMAS/, Journal of clinical oncology, 15(5), 1997, pp. 1730-1735
PHASE-II MULTICENTER STUDY OF HUMAN CD52 ANTIBODY IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: OSTERBORG A DYER MJS BUNJES D PANGALIS GA BASTION Y CATOVSKY D MELLSTEDT H RANKIN E TSEKOURAS C PANGALIS GA CAVALLI F SESSA C HUHN D MARCUS R MAUGHAN T POYNTON C NISSEN N CARNEY D BRITTINGER G UPPENKAMP M ELONEN E TEERENHOVI L",ENGERT,"WILLEMZE R KLUINNELEMANS J THOMAS J EPENETOS AA NETHERSELL A DYER M CATOVSKY D DICATO M BASTION Y COIFFIER B RANADA JMF CROWTHER D WOLL P RAEMAKAERS J DEPAUW B DEGOS L",GISSELLBRECHT,"REIFFERS J MELLSTEDT H FASSAS A ANAGNOSTOPOULOS A BUNJES D JAEGER U STAHEL RA
Citation: A. Osterborg et al., PHASE-II MULTICENTER STUDY OF HUMAN CD52 ANTIBODY IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of clinical oncology, 15(4), 1997, pp. 1567-1574
A NOVEL IMMUNOTOXIN RECOGNIZING THE EPITHELIAL GLYCOPROTEIN-2 HAS POTENT ANTITUMORAL ACTIVITY ON CHEMOTHERAPY-RESISTANT LUNG-CANCER
Authors: ZIMMERMANN S WELS W FROESCH BA GERSTMAYER B STAHEL RA ZANGEMEISTERWITTKE U
Citation: S. Zimmermann et al., A NOVEL IMMUNOTOXIN RECOGNIZING THE EPITHELIAL GLYCOPROTEIN-2 HAS POTENT ANTITUMORAL ACTIVITY ON CHEMOTHERAPY-RESISTANT LUNG-CANCER, Cancer immunology and immunotherapy, 44(1), 1997, pp. 1-9
T-CELL DERIVED CYTOKINES CO-STIMULATE PROLIFERATION OF CD40-ACTIVATEDGERMINAL CENTER AS WELL AS FOLLICULAR LYMPHOMA-CELLS
Authors: SCHMITTER D KOSS M NIEDERER E STAHEL RA PICHERT G
Citation: D. Schmitter et al., T-CELL DERIVED CYTOKINES CO-STIMULATE PROLIFERATION OF CD40-ACTIVATEDGERMINAL CENTER AS WELL AS FOLLICULAR LYMPHOMA-CELLS, Hematological oncology, 15(4), 1997, pp. 197-207
PREPARATION AND FUNCTIONAL-EVALUATION OF NEW DOXORUBICIN IMMUNOCONJUGATES CONTAINING AN ACID-SENSITIVE LINKER ON SMALL-CELL LUNG-CANCER CELLS
Authors: FROESCH BA STAHEL RA ZANGEMEISTERWITTKE U
Citation: Ba. Froesch et al., PREPARATION AND FUNCTIONAL-EVALUATION OF NEW DOXORUBICIN IMMUNOCONJUGATES CONTAINING AN ACID-SENSITIVE LINKER ON SMALL-CELL LUNG-CANCER CELLS, Cancer immunology and immunotherapy, 42(1), 1996, pp. 55-63
POTENT ANTITUMOR EFFECTS OF AN ANTI-CD24 RICIN A-CHAIN IMMUNOTOXIN IN-VITRO AND IN A DISSEMINATED HUMAN BURKITTS-LYMPHOMA MODEL IN SCID MICE
Authors: SCHNELL R KATOUZI AA LINNARTZ C SCHOEN G DRILLICH S HANSMANN ML SCHIEFER D BARTH S ZANGEMEISTERWITTKE U STAHEL RA DIEHL V ENGERT A
Citation: R. Schnell et al., POTENT ANTITUMOR EFFECTS OF AN ANTI-CD24 RICIN A-CHAIN IMMUNOTOXIN IN-VITRO AND IN A DISSEMINATED HUMAN BURKITTS-LYMPHOMA MODEL IN SCID MICE, International journal of cancer, 66(4), 1996, pp. 526-531
FATE OF CONTAMINATING T(14-18)(-CELLS DURING EX-VIVO EXPANSION OF CD34-SELECTED HEMATOPOIETIC PROGENITOR CELLS() LYMPHOMA)
Authors: WIDMER L PICHERT G JOST LM STAHEL RA
Citation: L. Widmer et al., FATE OF CONTAMINATING T(14-18)(-CELLS DURING EX-VIVO EXPANSION OF CD34-SELECTED HEMATOPOIETIC PROGENITOR CELLS() LYMPHOMA), Blood, 88(8), 1996, pp. 3166-3175
ASSOCIATION OF CD24 WITH THE KINASE C-FGR IN A SMALL-CELL LUNG-CANCERCELL-LINE AND WITH THE KINASE LYN IN AN ERYTHROLEUKEMIA CELL-LINE
Authors: ZARN JA ZIMMERMANN SM PASS MK WAIBEL R STAHEL RA
Citation: Ja. Zarn et al., ASSOCIATION OF CD24 WITH THE KINASE C-FGR IN A SMALL-CELL LUNG-CANCERCELL-LINE AND WITH THE KINASE LYN IN AN ERYTHROLEUKEMIA CELL-LINE, Biochemical and biophysical research communications, 225(2), 1996, pp. 384-391
RADIATION STUDIES ON B-CELL DIFFERENTIATION MARKER CD24 SCLC CLUSTER-4 ANTIGEN EXPRESSING AND NON-EXPRESSING LUNG-CANCER CELL-LINES AND MOUSE FIBROBLASTS/
Authors: WEBER E SCHMITTER D RESCH H ZARN JA WAIBEL R MABRY M HUGUENIN P STAHEL RA
Citation: E. Weber et al., RADIATION STUDIES ON B-CELL DIFFERENTIATION MARKER CD24 SCLC CLUSTER-4 ANTIGEN EXPRESSING AND NON-EXPRESSING LUNG-CANCER CELL-LINES AND MOUSE FIBROBLASTS/, International journal of radiation biology, 68(2), 1995, pp. 205-213
SHORT-TERM WEEKLY CHEMOTHERAPY FOLLOWED BY HIGH-DOSE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOBLASTIC AND BURKITT LYMPHOMAS IN ADULT PATIENTS
Authors: JOST LM JACKY E DOMMANNSCHERRER C HONEGGER HP MAURER R SAUTER C STAHEL RA
Citation: Lm. Jost et al., SHORT-TERM WEEKLY CHEMOTHERAPY FOLLOWED BY HIGH-DOSE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOBLASTIC AND BURKITT LYMPHOMAS IN ADULT PATIENTS, Annals of oncology, 6(5), 1995, pp. 445-451
HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FORMALIGNANT-LYMPHOMAS
Authors: STAHEL RA JOST LM PICHERT G WIDMER L
Citation: Ra. Stahel et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FORMALIGNANT-LYMPHOMAS, Cancer treatment reviews, 21(1), 1995, pp. 3-32
THE SMALL-CELL LUNG-CANCER ANTIGEN CLUSTER-4 AND THE LEUKOCYTE ANTIGEN CD24 ARE ALLELIC ISOFORMS OF THE SAME GENE (CD24) ON CHROMOSOME BAND6Q21
Authors: ZARN JA JACKSON DG BELL MV JONES T WEBER E SHEER D WAIBEL R STAHEL RA
Citation: Ja. Zarn et al., THE SMALL-CELL LUNG-CANCER ANTIGEN CLUSTER-4 AND THE LEUKOCYTE ANTIGEN CD24 ARE ALLELIC ISOFORMS OF THE SAME GENE (CD24) ON CHROMOSOME BAND6Q21, Cytogenetics and cell genetics, 70(1-2), 1995, pp. 119-125
FINAL REPORT OF A PHASE-II STUDY OF INTERLEUKIN-2 AND INTERFERON ALPHA IN PATIENTS WITH METASTATIC MELANOMA
Authors: KRUIT WHJ GOEY SH CALABRESI F LINDEMANN A STAHEL RA POLIWODA H OSTERWALDER B STOTER G
Citation: Whj. Kruit et al., FINAL REPORT OF A PHASE-II STUDY OF INTERLEUKIN-2 AND INTERFERON ALPHA IN PATIENTS WITH METASTATIC MELANOMA, British Journal of Cancer, 71(6), 1995, pp. 1319-1321
DELETION OF THE CD24 GENE ON CHROMOSOME BAND 6Q21 IS ASSOCIATED WITH TRANSFORMATION IN FOLLICULAR NON-HODGKINS-LYMPHOMAS
Authors: PICHERT G ZARN JA DOMMANNSCHERRER CC STAHEL RA
Citation: G. Pichert et al., DELETION OF THE CD24 GENE ON CHROMOSOME BAND 6Q21 IS ASSOCIATED WITH TRANSFORMATION IN FOLLICULAR NON-HODGKINS-LYMPHOMAS, Blood, 86(10), 1995, pp. 1360-1360
IDENTIFICATION OF 6 T(14-18) TRANSLOCATION CARRYING CLONES IN A PATIENT WITH A 12 YEAR HISTORY OF A LOW-GRADE LYMPHOMA
Authors: SCHMITTER D PESTALOZZI B STAHEL RA PICHERT G
Citation: D. Schmitter et al., IDENTIFICATION OF 6 T(14-18) TRANSLOCATION CARRYING CLONES IN A PATIENT WITH A 12 YEAR HISTORY OF A LOW-GRADE LYMPHOMA, Blood, 86(10), 1995, pp. 3277-3277
AUTOLOGOUS TRANSPLANTATION OF CD34-SELECTED AND IMMUNOMAGNETICALLY PURGED HEMATOPOIETIC PROGENITOR CELLS MEDIATES RAPID HEMATOLOGICAL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA()
Authors: WIDMER L PICHERT G JOST LM STAHEL RA
Citation: L. Widmer et al., AUTOLOGOUS TRANSPLANTATION OF CD34-SELECTED AND IMMUNOMAGNETICALLY PURGED HEMATOPOIETIC PROGENITOR CELLS MEDIATES RAPID HEMATOLOGICAL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA(), Blood, 86(10), 1995, pp. 9145-9145
ANTIGENS OF LUNG-CANCER - RESULTS OF THE 3RD INTERNATIONAL WORKSHOP ON LUNG-TUMOR AND DIFFERENTIATION ANTIGENS
Authors: STAHEL RA GILKS WR SCHENKER T
Citation: Ra. Stahel et al., ANTIGENS OF LUNG-CANCER - RESULTS OF THE 3RD INTERNATIONAL WORKSHOP ON LUNG-TUMOR AND DIFFERENTIATION ANTIGENS, Journal of the National Cancer Institute, 86(9), 1994, pp. 669-672
RANDOMIZED STUDY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HIGH-RISK LYMPHOID MALIGNANCIES
Authors: STAHEL RA JOST LM CERNY T PICHERT G HONEGGER H TOBLER A JACKY E FEY M PLATZER E
Citation: Ra. Stahel et al., RANDOMIZED STUDY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HIGH-RISK LYMPHOID MALIGNANCIES, Journal of clinical oncology, 12(9), 1994, pp. 1931-1938
ME1-ANTIBODY LABELING OF PRIMARY BRONCHOGENIC TUMORS AND EXTRAPULMONARY MALIGNANCIES
Authors: SKOV BG STAHEL RA HIRSCH F
Citation: Bg. Skov et al., ME1-ANTIBODY LABELING OF PRIMARY BRONCHOGENIC TUMORS AND EXTRAPULMONARY MALIGNANCIES, Lung cancer, 11(3-4), 1994, pp. 221-227
Risultati: 1-25 | 26-43